Laura Stoppel - 30 Jun 2021 Form 3 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Katherine Denby, Attorney-in-Fact
Issuer symbol
ABOS
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
3
Filing time
30 Jun 2021, 19:01:00 UTC
Next filing
17 Jun 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned